Data Security and Privacy: Managing HIPAA Obligations and the HITECH Act
Presented by Elsevier Business Intelligence
WHEN
- March 29, 2011 1:00 PM - 2:30 PM
DESCRIPTION
While hospitals and physicians have been dealing with HIT and ehealth issues since the passage of HIPAA in 1996, the world of drug and device manufacturers, are only just now seeing the potential and peril in dealing with massive quantities of electronic health information.
There are a variety of new HIPAA regulations that will directly impact pharmaceutical and medical device manufacturers. Anticipated changes include:
- Health data breach notification
- Enforcement of privacy and security regulations
- Modification to the HIPAA rules that were included in the HITECH Act
- Proposed rule on accounting for disclosures of electronic health records
Currently manufacturers must preserve private information and avoid privacy violations when conducting clinical trials, balancing due diligence obligations with data privacy and security laws, and adhering to the EU Privacy Directive.
In 90 minutes, Partners Colin Zick and Ara Gershengorn, along with Associate Sarah Altschuller, of Foley Hoag, will survey the key issues implicated by HIT and electronic health information. This webinar will inform you about the regulatory landscape and arm you with tools to help survive and thrive in the world of digitized health care.
During this webinar, you will learn:
- Overview of the U.S. legal environment: HIPAA, HITECH Act and other state laws
- Preparing for and responding to an internal data breach
- Dealing with third parties – What is a HIPAA business associate?
- Adhering to the EU Privacy Directive - What is the EU Privacy Directive?
- Creating a safe harbor: certifying your company for cross-border data transfer
- Potential legislative and regulatory developments for 2011 and beyond: Do Not Track and related consumer regulation, HITECH regulations